Schlosstein: M&A Activity Down on Scrutiny, not Economics

The video discusses the impact of aggressive antitrust regulations in the US and Europe, affecting major deals like Baker Hughes-Halliburton and Comcast-Time Warner. It highlights the scrutiny on large transactions, particularly in healthcare, and the effect of inversion regulations on the Pfizer-Allergan deal. The video also explores the regulatory perspective on such deals and the populist revolt against offshoring jobs, emphasizing the economic challenges of employment and taxation.

In what ways did US regulators respond to Pfizer's aggressive approach in pursuing a transaction?

What are the implications of the populist revolt against offshoring jobs on corporate transactions?